NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Establishment Labs Holdings Inc. (ESTA) Stock Analysis

Establishment Labs Holdings Inc. (ESTA) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

ESTA

$62.28

+$1.21 (+1.98%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare ESTA with… →

ESTA Key Statistics

As of Oct 21, 2026
Trading
Open
$61.50
Previous Close
$61.07
Day's Range
61.08–63.40
52-Week Range
47.00–97.59
Volume
474.80K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.06
Valuation
Market Cap
$1.86B
P/E Ratio
unprofitable
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
1,038.00
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
7.55
EPS (ttm)Profit attributable to each share over the last twelve months.
−1.30
Financials (FY)
Revenue (FY)
$211.08M+27.14%
Net Income (FY)
−$51.06M
Profit marginThe share of revenue left as profit after all costs and taxes.
−15.82%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
29.80M
1-Year Return
+26.25%
Dividend and dates
Earnings Date
October 29, 2026
Avg Volume
420.32K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, ESTA closed at $62.28, +26.25% over 1 year.

Establishment Labs Holdings Inc. (ESTA) has a market capitalization of $1.86B.

In fiscal 2025, ESTA reported revenue of $211.08M.

ESTA Stock Return by Calendar Year

Establishment Labs Holdings Inc. (ESTA) return since Jul 2018: what $10,000 became

1 year
$10,000 $12,625
+26.25%
5 years
$10,000 $8,131
−18.69%
Since Jul 2018
$10,000 $25,164
+151.64%

If you had invested $10,000 in Establishment Labs Holdings Inc. (ESTA) at the close on July 19, 2018, the earliest close on record here, it would have been worth $25,164 at the close on October 21, 2026: +151.64% in total, +11.82% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−14.54%
2025+58.19%
2024+77.95%
2023−60.56%
2022−2.87%
2021+79.57%
2020+36.08%
2019+0.88%
2018 (partial year)+10.79%

As of October 21, 2026.

ESTA Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$211.08M−$51.06M−24.2%
2024$166.03M−$84.60M−51.0%
2023$165.15M−$78.50M−47.5%
2022$161.70M−$75.21M−46.5%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$211.08M$146.31M−$39.01M−$51.06M−24.2%
2024$166.03M$109.53M−$49.99M−$84.60M−51.0%
2023$165.15M$106.98M−$65.03M−$78.50M−47.5%
2022$161.70M$106.60M−$39.66M−$75.21M−46.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

ESTA Valuation vs Medical Devices Median

Median of 145 stocks
MetricESTAMedical Devices medianvs median
P/S ratio7.552.53198% above
Profit margin−15.82%−14.78%1.0 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 17 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Establishment Labs Holdings Inc. (ESTA) is capitalised at $1.86B on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 1,004 employees.

Over the past 52 weeks the price has ranged from $47.00 to $97.59. ESTA last closed at $62.28 on October 21, 2026. That is +$1.21 (+1.98%) against the previous close. The latest close sits 32.51% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $211.08M. Against the prior fiscal year total of $166.03M, that is a change of +27.14%. The same year closed with a net loss of $51.06M. The reported profit margin is −15.82%. That is 1 percentage points below the Medical Devices median of −14.78%. Trailing earnings per share are −1.3.

Across the 4 fiscal years on file, revenue moves from $161.70M in 2022 to $211.08M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. On forward earnings the ratio is 1,038. Measured against sales, the shares trade at 7.55 times revenue. On price-to-sales that is 198.48% above the Medical Devices median of 2.53. 145 Medical Devices companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 1.06. Annualized volatility over the trailing 8 years is 66.88%. The trailing one-year total return is +26.25%. Measured over 5 years, that is −4.05% a year compounded.

Growth & Income

The record shows no dividend for ESTA.

2026 is still running; the total return is −14.54% year to date. The strongest complete calendar year on file is 2021 at +79.57%; the weakest is 2023 at −60.56%. Of the 7 complete calendar years on file, 5 finished higher.

Peer Comparison

Establishment Labs Holdings Inc. (ESTA) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Establishment Labs Holdings Inc. ESTA $1.86B —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

The Medical Devices industry average P/E ratio is 27.1x. Establishment Labs Holdings Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Establishment Labs Holdings Inc.

Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for breast aesthetic and reconstructive plastic surgeries in Europe, the Middle East, Africa, Latin America, Asia, and the United States. The company offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides breast tissue expanders. The company sells products to physicians, hospitals, and clinics through distributors and its direct sales force. Establishment Labs Holdings Inc. was incorporated in 2004 and is based in Austin, Texas.

Visit website →